REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,422,000 | -33.0% | 70,621 | -17.3% | 0.00% | 0.0% |
Q3 2018 | $2,122,000 | -2.2% | 85,377 | +8.0% | 0.00% | 0.0% |
Q2 2018 | $2,170,000 | -11.3% | 79,066 | -0.5% | 0.00% | 0.0% |
Q1 2018 | $2,447,000 | +0.4% | 79,437 | +16.5% | 0.00% | 0.0% |
Q4 2017 | $2,437,000 | +53.0% | 68,166 | +17.9% | 0.00% | +100.0% |
Q3 2017 | $1,593,000 | +7.2% | 57,822 | +2.7% | 0.00% | 0.0% |
Q2 2017 | $1,486,000 | +41.1% | 56,285 | +11.2% | 0.00% | 0.0% |
Q1 2017 | $1,053,000 | – | 50,613 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |